Halozyme Therapeutics
Halozyme Therapeutics, Inc.
11388 Sorrento Valley Road
San Diego, CA 92121
Phone: (858) 794 8889Website: https://www.halozyme.com/Careers: www.halozyme.com/Careers
Latest news
- FDA Approves Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) for Subcutaneous Use in Generalized Myasthenia Gravis
20 June 2023 - Halozyme Therapeutics Announces Submission of Investigational New Drug Application
30 June 2005 - Halozyme Therapeutics Files NDA for Enhanze SC
28 March 2005
Drugs Associated with Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc. manufactures, markets and/or distributes more than 2 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Hylenex
Generic name: hyaluronidase Drug class: miscellaneous uncategorized agents |
2 reviews | 5.5 / 10 |
|
Vyvgart Hytrulo
Generic name: efgartigimod alfa/hyaluronidase Drug class: immune globulins |
||
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||
